Navigation Links
Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
Date:1/22/2008

e pleased to see this significant scientific proof of concept and look forward to continuing the collaboration with Protalix toward commercializing the discoveries made by Professor Soreq and her team and bringing relief to patients around the world."

About Protalix BioTherapeutics, Inc.

Protalix is a biopharmaceutical company. Its goal is to become a fully integrated biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins to be expressed through its proprietary plant cell based expression system. Protalix's ProCellEx(TM) presents a proprietary method for the expression of recombinant proteins that Protalix believes is safe and scalable and will allow for the cost-effective, industrial-scale production of recombinant therapeutic proteins. Protalix is enrolling and treating patients in its pivotal phase III clinical trial in Israel, the United States and other locations for its lead product candidate, prGCD, for its enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder in humans, and has reached an agreement with the United States Food and Drug Administration on the final design of the pivotal phase III clinical trial through the FDA's Special Protocol Assessment (SPA) process. Protalix is also advancing additional recombinant biopharmaceutical drug development programs.

About Yissum

Yissum (http://www.yissum.co.il ) -- the technology transfer company of the Hebrew University of Jerusalem -- was founded in 1964 to protect the University's intellectual property and commercialize it. Today, more than $1 Billion in annual sales are generated by products based on Hebrew University technologies licensed out by Yissum. Ranked among the top technology transfer companies in the world, Yissum has registered 6,000 patents covering 1,600 inventions, licensed 450 technologies and spun out 60 companies.

Sa
'/>"/>

SOURCE Protalix BioTherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
2. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
3. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
4. FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
8. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
9. Researchers Use Magnetism to Target Cells to Animal Arteries
10. Novel Mechanism for Long-Term Learning Identified by Carnegie Mellon Researchers
11. Fals-Stewart Earns Hazeldens 2007 Dan Anderson Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...irstCall/ -- Unilens Vision Inc. (OTC Bulletin Boa...ops, licenses, manufactures, distributes and marke...erating results for the first quarter ended Septem...oyalty income, were $1,683,673 in the FY2010 first...e previous year first quarter (FY2009). The decre...
(Date:11/20/2009)...e-FirstCall/ -- Landauer, Inc. ( LDR) , will ...arter and full year of 2009 pre-market on Tuesday,...onference call for investors on Tuesday, December ...access the live call by dialing 877-941-9205 (with...(international callers), or by visiting the "Inves...
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Blood Pressure Monitoring & Measurement In...//www.reportlinker.com/p0164309/Blood-Pressure-Mon...Analysis.html#utm_source=prnewswire&utm_medium...t of blood pressure is not only an indicator of ca...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Viles 26 Beckman LLC 3A Stop Your Headache NOT Your Liver 50688 1Viles 26 Beckman LLC 3A Stop Your Headache NOT Your Liver 50688 2Cancer Endangers Some Wildlife Species 50683 1Cancer Endangers Some Wildlife Species 50683 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3
...6 Results from RESTORE 2, a,placebo-controlled, P...al,compound retigabine significantly reduced the n...y partial-onset epilepsy when a 600 mg or 900 mg d...c drug (AED) therapy. Prior to,enrollment in the r...ing,seizures despite taking stable doses of up to ...
... Dec. 6 Researchers today report that after the i... erythropoiesis-stimulating agents (ESAs), a signi...nts who were on chemotherapy and who received ESAs... of blood per patient than those patients who rece...tations. The findings from this observational stu...
Other Medicine Technology:Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 2Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 3Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 4Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 5Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 2Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 3Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 4Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 5Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion 6
(Date:11/23/2009)...cells in the brain is regulated by a peptide known...turation into nerve cells and is also important fo...in tissue, reveals new research from the Sahlgrens..., Although the research has been carried out usi... medicine for human beings, which could be given t...
(Date:11/23/2009)...-Science Focused Strategic Communications Agency H...on Professionals , Salem,...ife science-focused strategic communications agenc...arCom Gold Award in the design/website homepage ca...of Marketing and Communication Professionals. The ...
(Date:11/23/2009)...23/PRNewswire/--XiotechCorporationtodayannouncedth...(TM)7000storagesystem,poweredbyIntelligentStorageE...torageneeds,enablefuturegrowthanddeliversignifican...center. ,, MasonGeneral,locatedinShelton,Wash.,...e,s"MostWired-Rural"hospitalsin2008and2009foritssu...
(Date:11/23/2009)..., has understandably captured the attention of pub...wever, an analysis from Children,s Hospital Boston...nt (ED) during several recent flu seasons, shows t...V) -- takes a substantially greater disease toll a...though the data come from the pre-H1N1 influenza e...
(Date:11/23/2009)...longer to get sick, study finds , , MOND...that a genetic variation appears to play a major r... patients. , In fact, those with the variatio...die of complications of the disease. , "We,re... that make a person more or less susceptible to HI...
Breaking Medicine News(10 mins):Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3Health News:Genetic Variant Slows AIDS Progression 2
...INGTON, Dec. 2 Today Pascal Metrics Inc.,publicly...and risk management,services for hospitals and hea...l Metrics rapidly has become a worldwide leader fo...ke patients safer from,medical failure and errors....
...ER, Dec. 2 Barotz Dental is now one of only two d...r Assisted New Attachment,Procedure). This is the...d,and FDA approved for new attachment of gum and b...mizes pain and discomfort to the,patient, closes t...
...stmas Boxes Allow All to Celebrate With Traditiona... Angel Food Ministries ( www.angelfoodministries.c...quality food at low-costs, to anyone who wishes to...elebration. Host sites are now taking orders throu...
...ical Case Reviews Reveal Deficiencies in Care for ...c. 2 Members who recently sought expert medical ...eep uncertainty about their initial diagnosis or c...rs is a unique health benefit that calls upon top ...
...y Published Call to Action Highlights Need to Redu...ase Educational Efforts , , BETHESDA, Md., De...eases, (NFID) S.T.O.P. (Share. Teach. Outreach. ...prove adolescent meningococcal vaccination rates a...
...ls of tasimelteon show it could aid shift workers,...ec. 2 (HealthDay News) -- The experimental drug ta... jet lag or night shifts, according to the results...melteon, or a placebo. They were monitored for sev...
Other Medicine News:Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Angel Food Ministries to Distribute Holiday Grocery Relief 2Health News:Consumers Uncertain About Their Medical Diagnosis & Treatment 2Health News:Consumers Uncertain About Their Medical Diagnosis & Treatment 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:Drug Effective for Temporary Sleep Disruptions 2
...a compact RFID printing solution that can encode s...er/encoder is one of the most versatile in the ind...dia such as wristbands and smart labels, the R2844...er processing speed and more connectivity choices-...
HealthTrax Asset Tracking Software
...designed to protect a wandering resident from leav...ured. Such residents typically have been diagnosed... a head injury., At-risk residents wear a small W...nd points of exit are discreetly secured by WatchM...
PDC Smart™ Label
Medicine Products: